Browse diseases

…41 Figure 2Interpretability of gene contributions to metastatic melanoma classification using SHAP values…

…TRP-2, were generated using an established B16 melanoma-induced vitiligo model. 4 5 To determine Trm requirement for persistent antigen …

…p<0.001 (n=3)Abstract 359 Figure 2Tumor-trained splenocytes reg melanoma growth. (A) Low burden: B16 (1×104) + trained splenocytes (1×10…

… approval in 2014 but still fails in the majority of metastatic melanoma patients, emphasizing the need to further understand its impact…

… review, and overall survival (OS) in patients with BRAF-mutant melanoma, stratified by prior BRAFi treatment (data cutoff: March 8, 202…

…ME, hnRNP C synergizes with factors secreted by TAMs to promote melanoma cell migration and metastatic dissemination, in part via a CXCR…

…rrow niche alterations and hematopoietic clonal dynamicsResults Melanoma tumor cells infiltrate the bone marrow early, with disseminated…

…at TIM-3 levels were higher in the CD8+T cells of patients with melanoma who were non-responsive to immunotherapy. PD-1 and TIM-3 expres…

…over periocular LM, may have significant risk of progression to melanoma. Patients with PAM require careful eyelid examination to identi…

…1 interactions TiME sources of PD1 expression using FuncO:TIME: Melanoma FFPE samples collected from patient 27 pre- and post-treatment …

… to immunosuppressive programming in non-responders. In patient melanoma samples, a higher ratio of pro-inflammatory to immunosuppressiv…

…Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018;359:97–103.Overacre-Delgoffe AE, Bumgar…